The European and Developing Countries Clinical Trials Partnership (EDCTP) was created in 2003 with the aim to accelerate the development of new or improved drugs, vaccines and microbicides against HIV/AIDS, malaria and tuberculosis, with a focus on phase II and III clinical trials in sub-Saharan Africa.

Included within the EDCTP project profile is the PanACEA-REMoxTB project, which focuses on a shortened/simplified treatment for TB. The project consortium includes two TBD-UK members Professor Stephen Gillespie (University of St Andrews) and Dr Tim McHugh (UCL).

Most recently, EDCTP approved the capacity development project component of the PanACEA-REMoxTB consortium. This provides support for the development of African clinical trials capacity for tuberculosis studies.

Further details regarding this project and the work of the EDCTP can be viewed via their website (www.edctp.org)